Medical Uses
Roflumilast cream 0.3% (marketed as Zoryve), from Arcutis Biotherapeutics, is indicated for the topical treatment of plaque psoriasis, including intertriginous areas, in patients 6 years of age and older.
Roflumilast is a phosphodiesterase-4 (PDE4) inhibitor. By inhibiting PDE4, it reduces the production of pro-inflammatory cytokines in skin cells, helping to reduce the redness, thickness, and scaling of psoriasis plaques.
